A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study.
Chronic obstructive pulmonary disease (COPD) is a lung disease characterized with limitation of airflow that is not completely reversible, progressive deterioration of airways and systemic inflammation. This study has been planned to determine daily symptom variability of patients, expectations of patient and physicians from treatment and patient profiles. A total of 514 patients with COPD from 25 centers were included in this national, multicenter, cross-sectional observational study. Data regarding demographic features, concomitant diseases, history and treatment of COPD and expectations of patients and physicians were all obtained in a single visit. Mean [standard deviation (SD)] age of the patients was 64.1 (9.5) years; age range was 41-92 years, 50% of the patients were younger than 65 years and 91% were males. Educational level of the patients was at least primary school in 80.2%; and 54.3% (30.4%) of the patients had at least one concomitant disease, particularly a cardiovascular disease. Mean (SD) duration of having COPD was 5.4 (4.6) years. The majority of patients were at moderate (43.2%) and severe (35.0%) COPD stages and one or more exacerbations per year was determined in 71%. Inhaled beta-2 agonists (84.2%), inhaled steroids (76.3%) and inhaled long-acting anti-cholinergics (70.0%) were the most commonly used medications. Dyspnea (99.0%), sputum production (92.8%) and wheezing (90.5%) were the most common symptoms, and symptom variability for dyspnea (41.1%), sputum production (61.0%) and cough (53.5%) were seen the most in the morning hours (p< 0.001). Most commonly affected morning activity was climbing up/down the stairs (point of effect: 6.7), followed by wearing socks/shoes (point of effect: 4.3) and showering/bathing (point of effect: 4.2) by COPD. Major treatment expectations of patients were greater symptomatic relief (82.3%) and greater mobility (70.0%), faster symptomatic relief (61.1%) and improvement in morning activities (59.3%); while major treatment expectations of physicians included increased quality of life (100.0%) and decreased morbidity (96.0%). Quitting smoking was the most commonly recommended (88.3%) and implemented (67.9%) non-drug protective approach aimed at decreasing the frequency of exacerbations. Consequently, our results demonstrate that COPD is not a disease of only the elderly, is an important healthcare issue that often disrupt daily living of the patients due to inadequate disease awareness leading to overlooking of the symptoms by patient and physicians, and that a patient-centered approach based on the living standards, life expectancies and preferences of patients was crucial in patient management.
Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey. tnkuyucu@yahoo.com
Tülin
T
Kuyucu
Salih Zeki
SZ
Güçlü
Bengü
B
Saylan
Cahit
C
Demir
Tuncer
T
Senol
Serdar
S
Güner
Ejder
E
Koyuncu
Ferit
F
Ozen
Sezai
S
Oztürk
Zeki
Z
Cangül
Semih
S
Ağanoğlu
Sevket
S
Ozkaya
Sevilay Ciçek
SC
Ocak
Hüseyin
H
Akkurt
Yavuz Selim
YS
Intepe
Merve Gülcan
MG
Bayrak
Tuncay
T
Güler
Taha Tahir
TT
Bekçi
Sadan
S
Soyyiğit
Salim
S
Seyfettin
Ozhan
O
Kula
Makbule Ozlem
MO
Akbay
Bengü
B
Büyükgöze
Gökhan
G
Asal
Seyma
S
Başlilar
Osman
O
Oztürk
D000203:Activities of Daily Living; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002940:Circadian Rhythm; D003430:Cross-Sectional Studies; D018450:Disease Progression; D004417:Dyspnea / Q000453:epidemiology; D005100:Expectorants / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010820:Physicians / Q000523:psychology*; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications* / Q000188:drug therapy* / Q000401:mortality / Q000523:psychology; D011788:Quality of Life; D012720:Severity of Illness Index; D016540:Smoking Cessation
D001993:Bronchodilator Agents; D005100:Expectorants